日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety, Tolerability, Pharmacokinetics, and Viral Pharmacodynamics of the Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection in Participants with Early, Mild-to-Moderate COVID-19: A Randomized Clinical Trial

单克隆抗体 Sotrovimab 肌注治疗早期轻度至中度 COVID-19 患者的安全性、耐受性、药代动力学和病毒药效学:一项随机临床试验

Gupta, Anil; Perez-Rodríguez, Maria Teresa; Gonzalez-Rojas, Yaneicy; Ramgopal, Moti; Free, Almena; Han, Jennifer; Moore, Jennifer; Givens, Naomi; Yates, Phillip J; Walker, Jill T; Connolly, Mary Beth; Schnell, Gretja; Imber, Varsha; Anselm, Rabia; Winograd, Lindsay; Segal, Scott; Harrison, Stephen; Skingsley, Andrew; Aldinger, Melissa; Peppercorn, Amanda; Moya, Jaynier

Neutralization, effector function and immune imprinting of Omicron variants

Omicron变体的中和作用、效应功能和免疫印记

Amin Addetia #,Luca Piccoli #,James Brett Case #,Young-Jun Park #,Martina Beltramello,Barbara Guarino,Ha Dang,Guilherme Dias de Melo,Dora Pinto,Kaitlin Sprouse,Suzanne M Scheaffer,Jessica Bassi,Chiara Silacci-Fregni,Francesco Muoio,Marco Dini,Lucia Vincenzetti,Rima Acosta,Daisy Johnson,Sambhavi Subramanian,Christian Saliba,Martina Giurdanella,Gloria Lombardo,Giada Leoni,Katja Culap,Carley McAlister,Anushka Rajesh,Exequiel Dellota Jr,Jiayi Zhou,Nisar Farhat,Dana Bohan,Julia Noack,Alex Chen,Florian A Lempp,Joel Quispe,Lauriane Kergoat,Florence Larrous,Elisabetta Cameroni,Bradley Whitener,Olivier Giannini,Pietro Cippà,Alessandro Ceschi,Paolo Ferrari,Alessandra Franzetti-Pellanda,Maira Biggiogero,Christian Garzoni,Stephanie Zappi,Luca Bernasconi,Min Jeong Kim,Laura E Rosen,Gretja Schnell,Nadine Czudnochowski,Fabio Benigni,Nicholas Franko,Jennifer K Logue,Courtney Yoshiyama,Cameron Stewart,Helen Chu,Hervé Bourhy,Michael A Schmid,Lisa A Purcell,Gyorgy Snell,Antonio Lanzavecchia,Michael S Diamond,Davide Corti,David Veesler

Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial

高剂量静脉注射索托维单抗治疗轻度至中度 COVID-19 的安全性、病毒学、药代动力学和临床经验:一项开放标签临床试验

Moya, Jaynier; Temech, Marisol; Parra, Sergio; Juarez, Erick; Hernandez-Loy, Reinaldo; Gutierrez, Juan C Moises; Diaz, Jorge; Hussain, Rubaba; Segal, Scott; Xu, Claire; Skingsley, Andrew; Schnell, Gretja; El-Zailik, Asma; Sager, Jennifer E; Aldinger, Melissa; Alexander, Elizabeth L; Acloque, Gerard

Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study

在 III 期 COMET-ICE 研究中,对 COVID-19 患者接受 sotrovimab 治疗后的耐药性进行分析

Subramanian, Sambhavi; Schnell, Gretja; Iulio, Julia di; Gupta, Anil K; Shapiro, Adrienne E; Sarkis, Elias H; Lopuski, Amanda; Peppercorn, Amanda; Aldinger, Melissa; Hebner, Christy M; Cathcart, Andrea L

Imprinted antibody responses against SARS-CoV-2 Omicron sublineages

针对SARS-CoV-2 Omicron亚系的印迹抗体反应

Park, Young-Jun; Pinto, Dora; Walls, Alexandra C; Liu, Zhuoming; De Marco, Anna; Benigni, Fabio; Zatta, Fabrizia; Silacci-Fregni, Chiara; Bassi, Jessica; Sprouse, Kaitlin R; Addetia, Amin; Bowen, John E; Stewart, Cameron; Giurdanella, Martina; Saliba, Christian; Guarino, Barbara; Schmid, Michael A; Franko, Nicholas M; Logue, Jennifer K; Dang, Ha V; Hauser, Kevin; di Iulio, Julia; Rivera, William; Schnell, Gretja; Rajesh, Anushka; Zhou, Jiayi; Farhat, Nisar; Kaiser, Hannah; Montiel-Ruiz, Martin; Noack, Julia; Lempp, Florian A; Janer, Javier; Abdelnabi, Rana; Maes, Piet; Ferrari, Paolo; Ceschi, Alessandro; Giannini, Olivier; de Melo, Guilherme Dias; Kergoat, Lauriane; Bourhy, Hervé; Neyts, Johan; Soriaga, Leah; Purcell, Lisa A; Snell, Gyorgy; Whelan, Sean P J; Lanzavecchia, Antonio; Virgin, Herbert W; Piccoli, Luca; Chu, Helen Y; Pizzuto, Matteo Samuele; Corti, Davide; Veesler, David

HIV-1 is Transported into the Central Nervous System by Trafficking Infected Cells

HIV-1病毒通过感染细胞的运输进入中枢神经系统。

Kincer, Laura P; Schnell, Gretja; Swanstrom, Ronald; Miller, Melissa B; Spudich, Serena; Eron, Joseph J; Price, Richard W; Joseph, Sarah B

Efficacy and safety of glecaprevir/pibrentasvir in patients with HCV genotype 5/6: An integrated analysis of phase 2/3 studies

格卡瑞韦/哌仑他韦治疗HCV基因5/6型患者的疗效和安全性:一项2/3期研究的综合分析

Yao, Betty B; Fredrick, Linda M; Schnell, Gretja; Kowdley, Kris V; Kwo, Paul Y; Poordad, Fred; Nguyen, Kinh; Lee, Samuel S; George, Christophe; Wong, Florence; Gane, Edward; Abergel, Armand; Spearman, Catherine W; Nguyen, Tuan; Hung Le, Manh; Pham, Thuy Tt; Mensa, Federico; Asselah, Tarik

Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders

奥比他韦/帕瑞他韦/利托那韦和达沙布韦±利巴韦林用于治疗患有精神疾病的美国退伍军人的慢性丙型肝炎病毒感染

Fuchs, Michael; Monto, Alexander; Bräu, Norbert; Charafeddine, Mariem; Schmidt, Warren; Kozal, Michael; Naggie, Susanna; Cheung, Ramsey; Schnell, Gretja; Yu, Yao; Richards, Kristine; Mullally, Victoria; Cohen, Daniel E; Toro, Doris

Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir

对接受奥比他韦和帕瑞他韦/利托那韦治疗的日本患者的丙型肝炎病毒2型基因型进行耐药性特征分析

Schnell, Gretja; Tripathi, Rakesh; Krishnan, Preethi; Beyer, Jill; Reisch, Thomas; Irvin, Michelle; Dekhtyar, Tatyana; Setze, Carolyn; Rodrigues, Lino Jr; Alves, Katia; Burroughs, Margaret; Redman, Rebecca; Chayama, Kazuaki; Kumada, Hiromitsu; Collins, Christine; Pilot-Matias, Tami

Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials

在接受格卡瑞韦-哌仑他韦治疗的丙型肝炎病毒基因型 1 至 6 感染患者的 2 期和 3 期临床试验中进行的汇总耐药性分析

Krishnan, Preethi; Pilot-Matias, Tami; Schnell, Gretja; Tripathi, Rakesh; Ng, Teresa I; Reisch, Thomas; Beyer, Jill; Dekhtyar, Tatyana; Irvin, Michelle; Xie, Wangang; Larsen, Lois; Mensa, Federico J; Collins, Christine